Bandingkan Harga & Kinerja Esta Multi Usaha Tbk. (ESTA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Esta Multi Usaha Tbk. dan Organon Pharma Indonesia Tbk.: Esta Multi Usaha Tbk. diperdagangkan di Rp172 (kapitalisasi pasar 422,01 M, volume 24 jam 3,9 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Esta Multi Usaha Tbk. jauh lebih besar — sekitar 4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ESTA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 422,01 M | 104,4 M |
Volume | 3,9 jt | — |
Lot | 39,02 rb | — |
Perputaran | 691,55 jt | — |
Harga Rata-rata | 177,25 | — |
Nilai Transaksi | 691,55 jt | — |
Harga Ekuilibrium Indikatif | 172 | — |
Volume Ekuilibrium Indikatif | 235 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Esta Multi Usaha Tbk.
PT Esta Multi Usaha Tbk (the “Company”) was established under the name PT Esta Asri Propertindo, based on Notarial Deed No. 34 dated September 30, 2011 of Kun Hidayat, S.H., notary in Jakarta. The Company started its commercial operations in 2012. Until 2017, the Company only did real estate leasing business activities. In 2018, the Company started its hospitality business activities.Whereas in 2019, the Company commenced vehicle rental business activities without option rights.
Selengkapnya di halaman ESTA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
